The Impella percutaneous ventricular assist device
Esfandiari S, Erickson L, McGregor M
Record ID 32010000170
English
Authors' recommendations:
The Impella® device is clearly more clinically effective than IABP or ECMO. It is also less traumatic and less expensive than other available ventricular assist devices.In the context of an institution in which the decision has already been made to provide mechanical support of acute vascular collapse, the use of Impella® can be cost saving.However, case selection is critical. Used too early, when patients could have survived without its use , Impella® use is unproductive and expensive. Used too late, when pump failure, end-organ failure or brain death are irreversible its use is wasteful.Review of current use of this technology at the MUHC indicates that utilisation is restrained and appropriate.
Details
Project Status:
Completed
URL for project:
http://www.mcgill.ca/files/tau/IMPELLA_FINAL_JUNE_2009.pdf
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Costs and Cost Analysis
- Myocardial Infarction
- Ventricular Dysfunction, Left
Contact
Organisation Name:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
Contact Address:
Technology Assessment Unit of the MUHC, 536-5100 Boul. Maisonneuve O, Montreal, H4A 3T2
Contact Name:
eva.suarthana@mcgill.ca
Contact Email:
nisha.almeida@muhc.mcgill.ca
Copyright:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.